Sarepta Therapeutics (SRPT) Other financing activities (2013 - 2026)
Sarepta Therapeutics (SRPT) posted quarterly Other financing activities of $241000.0 for Q1 2026, down 98.46% year-over-year from $15.7 million in Q1 2025, and down 21.75% quarter-over-quarter from $308000.0 in Q4 2025.
Sarepta Therapeutics (SRPT) Other financing activities (2013 - 2026) Analysis & Trends
Sarepta Therapeutics' Other financing activities history runs 12 years deep, the most recent figure standing at $241000.0 for Q1 2026.
- In Q1 2026, Other financing activities fell 98.46% year-over-year to $241000.0; the TTM figure through Mar 2026 stood at $3.3 million (down 95.53% YoY), while the FY2025 annual figure was $18.7 million, down 76.48% from the prior year.
- Other financing activities for Q1 2026 stood at $241000.0, down from $308000.0 in the prior quarter.
- The five-year high for Other financing activities was $39.9 million in Q2 2024, with the low at $241000.0 in Q1 2026.
- The 5-year median for Other financing activities is $5.9 million (2023), against an average of $10.6 million.
- The sharpest annual moves came in 2023 and 2026: Other financing activities jumped 1628.91% in 2023, then plunged 98.46% in 2026.
- Sarepta Therapeutics' Other financing activities stood at $11.3 million in 2022, then sank by 82.81% to $1.9 million in 2023, then soared by 90.94% to $3.7 million in 2024, then tumbled by 91.7% to $308000.0 in 2025, then declined by 21.75% to $241000.0 in 2026.
- Business Quant data shows SRPT's Other financing activities at $241000.0 in Q1 2026, $308000.0 in Q4 2025, and $1.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Sarepta Therapeutics | 1.91 Bn | 1.12 Bn | 251.87 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 241,000.00 |
| Mar 31, 2026 | 241,000.00 |
| Dec 31, 2025 | 308,000.00 |
| Dec 31, 2025 | 308,000.00 |
| Sep 30, 2025 | 1.21 Mn |
| Sep 30, 2025 | 1.21 Mn |
| Jun 30, 2025 | 1.50 Mn |
| Jun 30, 2025 | 1.50 Mn |
| Mar 31, 2025 | 15.68 Mn |
| Mar 31, 2025 | 15.68 Mn |
| Dec 31, 2024 | 3.71 Mn |
| Dec 31, 2024 | 3.71 Mn |
| Sep 30, 2024 | 13.76 Mn |
| Sep 30, 2024 | 13.76 Mn |
| Jun 30, 2024 | 39.92 Mn |
| Jun 30, 2024 | 39.92 Mn |
| Mar 31, 2024 | 22.14 Mn |
| Mar 31, 2024 | 22.14 Mn |
| Dec 31, 2023 | 1.94 Mn |
| Dec 31, 2023 | 1.94 Mn |